Biofarm reported net profit of RON12.27 million and sales of RON52.92 million in the first six months of 2012.
Its revenues increased by 10.3% on the year to RON61.63 million in January through June, while expenses rose 12.3% to RON45.97 million in the mentioned interval.
Biofarm estimates nearly 10% higher sales in 2013 to RON115.1 million, but 10% lower net profit to RON19 million.
Romanian regional investment funds SIF Oltenia (SIF5.RO), SIF Banat Crisana (SIF1.RO) and SIF Moldova (SIF2.RO) own together around 54% of Biofarm’s shares.
On the Bucharest bourse Wednesday, Biofarm traded down 0.46% at RON0.26 a share.